Systematic review: IL-12/23 or IL-23 antagonists and RTIs or ILD

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453847/
http://dx.doi.org/10.1007/s40278-020-82554-0
_version_ 1783575428541186048
collection PubMed
description
format Online
Article
Text
id pubmed-7453847
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-74538472020-08-28 Systematic review: IL-12/23 or IL-23 antagonists and RTIs or ILD Reactions Weekly Clinical Study Springer International Publishing 2020-08-29 2020 /pmc/articles/PMC7453847/ http://dx.doi.org/10.1007/s40278-020-82554-0 Text en © Springer International Publishing AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical Study
Systematic review: IL-12/23 or IL-23 antagonists and RTIs or ILD
title Systematic review: IL-12/23 or IL-23 antagonists and RTIs or ILD
title_full Systematic review: IL-12/23 or IL-23 antagonists and RTIs or ILD
title_fullStr Systematic review: IL-12/23 or IL-23 antagonists and RTIs or ILD
title_full_unstemmed Systematic review: IL-12/23 or IL-23 antagonists and RTIs or ILD
title_short Systematic review: IL-12/23 or IL-23 antagonists and RTIs or ILD
title_sort systematic review: il-12/23 or il-23 antagonists and rtis or ild
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453847/
http://dx.doi.org/10.1007/s40278-020-82554-0

Ejemplares similares